Sosei Heptares and Verily Nominate First G-protein-coupled receptor Target for Therapeutic Development

Nomination of novel drug target based on insights generated through application of Verily’s Immune Profiler platform and Sosei Heptares’ GPCR-focused structure-based drug design expertise

...

Related Keywords

Japan ,United Kingdom ,London ,City Of ,Tokyo ,Seoul ,Soult Ukpyolsi ,South Korea ,Sosei Heptares ,Charlie Kim ,Sosei Heptare ,Matt Barnes ,Sosei Group ,Tokyo Stock Exchange ,European Federation Of Crohn Ulcerative Colitis Associations ,Sosei Group Corporation ,Twitter ,Sosei Group Corporation Heptares ,Research Use ,Youtube ,Linkedin ,Heptares Therapeutics ,Immune Profiler ,Molecular Science ,European Federation ,Ulcerative Colitis Associations ,Group Corporation ,Markets ,